Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04210986 · ClinicalTrials.gov registry record · Phase 1
Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial
A Phase 1 study, sponsored by Steadman Philippon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT04210986: Completed Phase 1 study, sponsored by Steadman Philippon Research Institute.
NCT04210986 is a Phase 1 study that has completed, run by Steadman Philippon Research Institute. The registered enrollment target is 75 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04210986, a Phase 1 study, has completed, sponsored by Steadman Philippon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis
Primary Outcome
Number of Participants Experiencing one or more Treatment-Emergent Adverse Event (TEAE) within each group.
Interventions
- DRUG Placebo oral capsule
- DIETARY_SUPPLEMENT Fisetin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2023-02-01 |
| Phase | Phase 1 |
What the finished NCT04210986 record still lists
NCT04210986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT04210986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04210986 about?
NCT04210986 is a clinical study titled "Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial". Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis
What is the current status of trial NCT04210986?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2020-01-06. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT04210986?
The interventions under investigation include: Placebo oral capsule (DRUG), Fisetin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04210986?
This trial is sponsored by Steadman Philippon Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04210986's enrollment target sits among peer trials
75 711th of 2000 higher than 1,276 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI